Research shows that cutting calories by 30%, especially when combined with metformin, reduced belly fat in middle-aged female mice with inherited high cholesterol. However, neither approach normalized cholesterol, triglycerides, or blood sugar, according to research reviewed by Gram in this 2026 study.
Gram Research analysis of a 2026 study in the journal Anais da Academia Brasileira de Ciencias looked at whether eating 30% fewer calories, with or without the diabetes drug metformin, could help mice that inherit very high cholesterol. The mice were middle-aged females that lack a receptor needed to clear cholesterol from the blood, a setup that mirrors a human genetic condition called familial hypercholesterolemia. Both approaches reduced weight gain and belly fat, and the combination worked best. However, neither approach brought cholesterol, triglycerides, or blood sugar back to normal. Some behavior changes improved, such as less hyperactivity and a small boost in short-term memory for a scary event, but problems with recognition memory and anxiety-like behavior stayed the same. The results suggest these tools may help with body fat, but they did not fix the deeper problems in this model. Because the study used mice, its findings cannot yet be applied directly to people.
Key Statistics
A 2026 mouse study published in Anais da Academia Brasileira de Ciencias found that a 30% calorie reduction lowered visceral belly fat in middle-aged female mice with inherited high cholesterol, and adding metformin produced a stronger effect.
The same 2026 study reported that neither the calorie reduction nor metformin normalized plasma cholesterol, triglycerides, or glucose levels in the high-cholesterol mice after a 6-hour fast.
According to the 2026 study, the combined calorie reduction and metformin treatment modestly improved short-term aversive memory in mice, while recognition memory and anxiety-like behavior stayed impaired in all groups.
The Quick Take
- What they studied: Can cutting calories by 30%, alone or with the diabetes drug metformin, improve body weight, cholesterol, blood sugar, and thinking and behavior in mice with a genetic form of very high cholesterol?
- Who participated: Middle-aged female mice bred to lack a cholesterol-clearing receptor, which copies a human inherited condition. A group of healthy mice with normal cholesterol served as the comparison. The exact number of mice was not listed in the summary provided.
- Key finding: Eating 30% fewer calories reduced weight gain and belly fat, and adding metformin made the fat loss stronger. Neither approach lowered cholesterol, triglycerides, or blood sugar to normal levels.
- What it means for you: This study does not show that eating less or taking metformin will fix high cholesterol. It hints that calorie control may help with belly fat, but human results would need to be tested in people before any changes are made.
The Research Details
Researchers used a mouse model of familial hypercholesterolemia, an inherited condition where the body struggles to remove a type of cholesterol called LDL from the blood. The mice were missing the LDL receptor, a protein that normally pulls this cholesterol out of the bloodstream. Because these mice have high cholesterol from birth, they are a common tool for studying this disease.
The mice were split into groups. Some ate normal amounts of food, some ate 30% less food, and some ate 30% less food while also drinking water that contained metformin. A group of healthy mice with normal cholesterol was included for comparison. The team tracked body weight, belly fat, blood fats, blood sugar, and inflammation markers. They also ran behavior tests that measure movement, anxiety, and memory.
The mice were studied after a 6-hour fast so that blood test results could be compared fairly. The behavior tests used familiar mouse tasks, such as exploring a maze and learning to avoid a small step that gave a mild shock. These tests are useful for early research but do not perfectly match human thinking or mood.
Using mice that carry the same genetic change as a human condition helps researchers see whether a treatment works on the disease process itself. Comparing the fasting-restricted groups with normal-eating mice and healthy controls shows which changes come from the diet and drug, and which come from the genetics. Tracking body, blood, and behavior measures together gives a more complete picture than any single test could.
The study used a recognized animal model and a healthy control group, which strengthens the comparison. Measuring several outcomes at once is a strength. However, the summary does not list how many mice were in each group, and it covers only female mice, so results may not apply to males. Because this is an animal study, findings are early and need to be confirmed in human research before they guide care.
What the Results Show
Cutting calories by 30% slowed weight gain and reduced visceral fat, which is the fat stored deep in the belly around organs. The effect was stronger when metformin was added to the drinking water. This suggests that the two approaches may work together on body fat.
Despite these gains in body weight, neither approach brought blood cholesterol, triglycerides, or blood sugar back to healthy levels. The mice still had the high cholesterol caused by their genetic change. In other words, the treatments changed how much fat the mice carried, but they did not correct the underlying lipid problem.
Behavior results were mixed. Calorie restriction reduced the unusually high activity level seen in these mice during a maze test, which may suggest a calmer pattern of movement. Recognition memory and anxiety-like behavior remained impaired in every group, so these areas did not improve with either approach.
The combined treatment modestly improved short-term aversive memory in the step-down task, meaning the mice remembered a scary experience a bit better over a short period. Inflammation levels of a signaling molecule called interleukin-1 beta in the brain did not differ meaningfully between groups.
Inflammation markers in the hippocampus and prefrontal cortex, two brain areas tied to memory and decision-making, were similar across groups. This suggests that the treatments did not measurably calm brain inflammation in this model. The small memory gain from the combined treatment is interesting, but it was limited to one type of memory test and one time frame, so it should be viewed as a preliminary signal rather than a clear benefit.
Earlier research has shown that calorie restriction can reduce body fat and improve metabolic health in many animal models. Metformin is widely used in people with type 2 diabetes and has been studied for its effects on weight and blood sugar. This study adds to that work by showing that these approaches may reduce belly fat even in mice with inherited high cholesterol, while still leaving cholesterol and memory problems largely unchanged. This suggests that controlling weight alone may not be enough to correct a genetic cholesterol disorder.
The study was done in mice, which do not perfectly match human biology, diet, or thinking. Only middle-aged female mice were studied, so the findings may not apply to males or younger or older individuals. The summary does not list the exact number of mice in each group, which makes it harder to judge how strong the results are. The behavior tests are simple tasks that may not capture the full range of human memory or mood problems. The study also measured cholesterol and blood sugar after a short fast, which may not reflect how these levels change over a full day or over years.
The Bottom Line
Based on this mouse study, the evidence suggests that calorie control and metformin may help reduce belly fat, which is linked to heart and metabolic health (moderate confidence for the mouse findings, low confidence for people). The study does not support using these approaches alone to lower cholesterol in inherited high-cholesterol conditions (confidence is reasonably high that they did not do so in this model). People with familial hypercholesterolemia should follow guidance from their own doctors, which usually includes cholesterol-lowering medicines and not diet changes alone.
Researchers studying inherited cholesterol disorders, brain health, and weight management may find this work useful for planning future studies. People with familial hypercholesterolemia or a family history of very high cholesterol should talk with their doctor before changing their diet or medications. Healthcare teams may find the belly fat results interesting, but the study does not give clinical instructions for patients. Anyone taking metformin should not start or stop it based on this research.
Results in mice cannot be directly translated into a timeline for people. Any human studies would take months to years to measure changes in cholesterol, body fat, and memory. Even if benefits to belly fat appear in people, it would likely take several months of steady changes in eating and activity to see a measurable difference on a scale or in blood tests.
Frequently Asked Questions
Does eating less help lower cholesterol in people with familial hypercholesterolemia?
A 2026 mouse study found that a 30% calorie reduction did not normalize cholesterol levels in mice with inherited high cholesterol, though it reduced belly fat. Human results may differ, so people with this condition should follow their doctor’s treatment plan.
Can metformin reduce belly fat in mice?
In a 2026 study, metformin added to drinking water made the belly fat reduction from calorie restriction stronger in middle-aged female mice. It did not bring blood cholesterol, triglycerides, or glucose to healthy levels, according to research reviewed by Gram.
What did the 2026 mouse study find about memory and calorie restriction?
The combined calorie restriction and metformin treatment modestly improved short-term memory for a scary event in mice. Recognition memory and anxiety-like behavior remained impaired in all groups, suggesting limited cognitive benefit overall.
Are the results of this mouse study safe to apply to my diet?
This study used mice with a genetic cholesterol condition, so its results cannot be directly applied to people. Anyone considering a major calorie cut or starting metformin should consult a doctor first, especially if they have high cholesterol.
Want to Apply This Research?
- Track daily total calories and weekly waist circumference measured at the same spot, such as the belly button. Log these numbers in the app for at least 12 weeks, and record fasting blood test results from your doctor if available.
- Set a daily calorie target that is about 10% to 20% below your usual intake, as a practical step that is easier to sustain than a 30% cut. Use the app to log meals and flag days when you go over your target. Pair this with regular walking, which supports heart and metabolic health.
- Review waist measurements and calorie logs monthly to spot trends. Share the data with your doctor at regular checkups, especially if you have high cholesterol, so that any lipid testing and medication decisions are based on complete information. Adjust your plan only with professional guidance, particularly if you take metformin or other prescription medicines.
This article discusses a preclinical study conducted in mice, not people, and its findings may not apply to humans. Familial hypercholesterolemia is a serious inherited condition that needs medical care. Do not change your diet, cholesterol medicines, or metformin use based on this research. Talk with your doctor or a registered dietitian before making changes to your eating habits or treatment plan.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.